GIB-FMT is a Eurostars-funded collaboration between Gut in Balance, Medesign, Harro Höfliger and Hvidovre Hospital, developing automated manufacturing of FMT capsules for hospital-based production.
About the technologyOur objective is to make FMT capsule production more accessible, scalable and reliable by developing an automated, hospital-based production platform.
Develop controlled workflows for consistent and reproducible capsule manufacturing.
Give hospitals the infrastructure to produce FMT capsules within their own clinical settings.
Support controlled processing, documented workflows and traceability from donor material to finished capsules.
Build on laboratory-validated storage stability of up to four years at −80°C.
Develop production infrastructure with the EU SoHO framework, applicable quality requirements and future hospital implementation in mind.
Work towards reducing production costs and making FMT treatment more accessible to patients.
Role: Project Coordinator and Technology Developer
Responsible for overall project management, coordination of project partners, and monitoring of milestones, deliverables and progress. The company is the originator of the project concept and is responsible for the development and commercialisation of the FMT capsule technology and automated production platform, including the associated intellectual property.
Role: Industrialisation and Manufacturing Partner
Contributes expertise in medical device development, bag design and manufacturing. Responsible for supporting the industrialisation of the FMT processing bags, including prototype development, material selection, manufacturing feasibility and preparation for scalable production.
Role: Clinical Partner
Contributes clinical expertise in FMT treatment and supports the preparation of a suitable hospital laboratory environment for the capsule production platform. Provides clinical input to the project, supports planning for future testing and helps ensure that the technology is developed to meet the practical needs of hospital-based FMT production.
Role: Capsule Filling Machine Engineering and Manufacturing Partner
Responsible for the engineering and manufacturing of the capsule filling machine prototype. Contributes expertise in machine design, precision engineering and pharmaceutical production technology to support the development of an automated FMT capsule filling solution for hospital-based production.
Further updates on project milestones, technical development and dissemination activities will be published here as the project progresses.
The GIB-FMT project has been invited to give an oral presentation at NorMIC 26th of August 2026 in Finland. This provides an opportunity to present the project’s development of an automated FMT capsule production platform to the scientific community and share our progress towards more standardised, hospital-based production.
The GIB-FMT project was presented as a poster at Nordic Innovation Fair 2026. The event provided an opportunity to showcase our innovative approach to FMT capsule production and raise awareness of the project’s potential to support more accessible and scalable hospital-based manufacturing.
The University of Copenhagen (KU), in collaboration with Hvidovre Hospital, has initiated a larger study involving patients with anorexia nervosa in Denmark, supported by DKK 7.2 million in funding from the Lundbeck Foundation.
The study uses GIB-FMT capsules produced with Gut in Balance’s existing bag-based manual production system, which integrates homogenisation, filtration and dosing, to investigate the potential role of gut microbiota-based treatment in anorexia nervosa.
This clinical research represents an important step towards exploring new treatment approaches and advancing scientific understanding of the relationship between the gut microbiota and anorexia nervosa. It also demonstrates the clinical application of existing production technology as we develop our next-generation automated capsule manufacturing platform.
Forthcoming.
Publications and presentations from the project will be listed here. Related clinical work is on the Clinical Evidence page.
This project is funded under the Eurostars programme.